Deaths halved among infarct patients attending ‘Heart School’

Organisation: Position: Deadline Date: Location:

Patients who attend “Heart School”, as almost every patient in Sweden is invited to do after a first heart attack, live markedly longer than non-participating patients. This is shown in study by researchers at Uppsala University.

Patient education is an important aspect of rehabilitation after a heart attack (myocardial infarction). Core components of Sweden’s “Heart School” are individual counselling and group sessions focused on lifestyle-related, modifiable risks. Thus, patients are taught the importance of maintaining a healthy diet, being physically active and giving up smoking. Almost all patients with a first-time myocardial infarction are invited to participate. However, Heart School attendance is voluntary and fewer than half the patients choose to join.

This study represents the first scientific evaluation of Heart School in relation to mortality after myocardial infarction. To investigate the relationship between Heart School participation and how long patients survive after a first heart attack, the researchers used ten years’ data from the nationwide Swedish heart registry SWEDEHEART (Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies) and the Swedish Cause of Death Register. Socioeconomic variables were obtained from Statistics Sweden (SCB).

The researchers’ material comprised 47,907 patients who had their first heart attack in 2006-2015 and subsequently went to the first CR follow-up visit. Among them, time to total death (from all causes) and death from cardiovascular causes within two and five years after the attack were investigated. The data enabled the scientists to control for a range of other important confounding variables, such as demographic and socioeconomic factors, and other aspects of the patients’ cardiac health.

After adjusting for confounding variables, the researchers found that attendance at Heart School was associated with a markedly lower risk (time to outcome) not only for total mortality, but also for cardiovascular mortality. With up to two years’ follow-up, the Heart School participants’ risk of dying was reduced by 47% (50% risk reduction for death from cardiovascular causes). After up to five years, the follow-up results showed a 38% lower mortality risk (43% lower for death from cardiovascular causes).

“We can say that Heart School attendance was associated with almost halved mortality, both total and specifically cardiovascular, after a first myocardial infarction,” says John Wallert, licensed psychologist and doctoral student at the department of women’s and children’s health, Uppsala University.

The results were consistent across several sensitivity analyses, including varying dates of Heart School attendance and supplementary checks for participation in other cardiac rehabilitation programmes, among patients who also succeeded in achieving complete cardiac rehabilitation, after gender and age stratification etc.

“We were a little surprised at how robust the results were. In this study, thanks to Sweden’s exceptional registry data, we have the means of controlling for not only clinical and demographic factors, but also factors related to self-selection and socioeconomic variables, such educational attainment and income. Data also provided the statistical power to achieve precise estimates and to allow for a range of sensitivity analyses
“Now we want to determine whether the association of attending Heart School with mortality is genuinely one of cause and effect. Ideally, we’ll find this out in a large enough randomised clinical trial, preferably a registry-based one,” Wallert says.

Abstract
Background: The Heart School is a standard component of cardiac rehabilitation after myocardial infarction in Sweden. The group-based educational intervention aims to improve modifiable risks, in turn reducing subsequent morbidity and mortality. However, an evaluation with respect to mortality is lacking.
Aims: Using linked population registries, we estimated the association of attending Heart School with both all-cause and cardiovascular mortality, two and five years after admission for first-time myocardial infarction.
Methods: Patients with first-time myocardial infarction (<75 years) were identified as consecutively registered in the nationwide heart registry, SWEDEHEART (2006–2015), with >99% complete follow-up in the Causes of Death registry for outcome events. Of 192,059 myocardial infarction admissions, 47,907 unique patients with first-time myocardial infarction surviving to the first cardiac rehabilitation visit constituted the study population. The exposure was attending Heart School at the first cardiac rehabilitation visit 6–10 weeks post-myocardial infarction. Data on socioeconomic status was acquired from Statistics Sweden. After multiple imputation, propensity score matching was performed. The association of exposure with mortality was estimated with Cox regression and survival curves.
Results: After matching, attending Heart School was associated (hazard ratio (95% confidence interval)) with a markedly lower risk of both all-cause (two-year hazard ratio = 0.53 (0.44–0.64); five-year hazard ratio = 0.62 (0.55–0.69)) and cardiovascular (0.50 (0.38–0.65); 0.57 (0.47–0.69)) mortality. The results were robust in several sensitivity analyses.
Conclusions: Attending Heart School during cardiac rehabilitation is associated with almost halved all-cause and cardiovascular mortality after first-time myocardial infarction. The result warrants further investigation through adequately powered randomised trials.

Authors
John Wallert, Erik MG Olsson, Ronnie Pingel, Fredrika Norlund, Margret Leosdottir, Gunilla Burell, Claes Held

Uppsala University material European Journal of Preventative Cardiology abstract

Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.